MONASTERO, Roberto
 Distribuzione geografica
Continente #
NA - Nord America 11.927
EU - Europa 5.794
AS - Asia 5.272
SA - Sud America 939
AF - Africa 179
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 7
AN - Antartide 1
Totale 24.137
Nazione #
US - Stati Uniti d'America 11.713
SG - Singapore 1.961
IT - Italia 1.622
RU - Federazione Russa 1.538
CN - Cina 1.224
BR - Brasile 758
HK - Hong Kong 534
VN - Vietnam 516
DE - Germania 469
FI - Finlandia 396
PL - Polonia 334
UA - Ucraina 325
BD - Bangladesh 266
FR - Francia 256
GB - Regno Unito 256
IE - Irlanda 196
JP - Giappone 165
IN - India 110
CA - Canada 105
KR - Corea 90
TR - Turchia 90
NL - Olanda 75
SE - Svezia 72
IQ - Iraq 61
AR - Argentina 58
RO - Romania 49
AT - Austria 46
CI - Costa d'Avorio 45
MX - Messico 41
BE - Belgio 40
ZA - Sudafrica 37
EC - Ecuador 31
ID - Indonesia 30
ES - Italia 28
PK - Pakistan 28
MA - Marocco 27
CO - Colombia 24
IR - Iran 24
UZ - Uzbekistan 22
SA - Arabia Saudita 21
JM - Giamaica 20
VE - Venezuela 19
MY - Malesia 18
AU - Australia 17
CH - Svizzera 15
CL - Cile 14
NP - Nepal 14
GR - Grecia 13
AE - Emirati Arabi Uniti 12
JO - Giordania 12
LT - Lituania 12
SC - Seychelles 12
BG - Bulgaria 11
DZ - Algeria 11
KE - Kenya 11
PE - Perù 11
TN - Tunisia 11
EG - Egitto 10
PY - Paraguay 9
CR - Costa Rica 8
CZ - Repubblica Ceca 8
IL - Israele 8
KZ - Kazakistan 8
BO - Bolivia 7
UY - Uruguay 7
AL - Albania 6
AZ - Azerbaigian 6
PA - Panama 6
PS - Palestinian Territory 6
BH - Bahrain 5
EU - Europa 5
HN - Honduras 5
LB - Libano 5
NI - Nicaragua 5
PH - Filippine 5
PT - Portogallo 5
RS - Serbia 5
TW - Taiwan 5
AN - Antille olandesi 4
BY - Bielorussia 4
DO - Repubblica Dominicana 4
OM - Oman 4
TH - Thailandia 4
BB - Barbados 3
GT - Guatemala 3
KG - Kirghizistan 3
NG - Nigeria 3
QA - Qatar 3
TT - Trinidad e Tobago 3
CY - Cipro 2
EE - Estonia 2
ET - Etiopia 2
GE - Georgia 2
HU - Ungheria 2
LK - Sri Lanka 2
MQ - Martinica 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SV - El Salvador 2
A2 - ???statistics.table.value.countryCode.A2??? 1
Totale 24.109
Città #
Ashburn 1.452
Singapore 1.346
Fairfield 1.290
San Jose 716
Woodbridge 679
Chandler 633
Houston 606
Wilmington 509
Seattle 508
Hong Kong 487
Cambridge 431
Dallas 427
Ann Arbor 337
Palermo 307
Zgierz 304
Moscow 301
Beijing 221
Dublin 195
Medford 193
Council Bluffs 189
Santa Clara 181
Des Moines 174
New York 174
Ho Chi Minh City 172
Jacksonville 161
Tokyo 158
Los Angeles 151
Lauterbourg 140
Frankfurt am Main 139
Hanoi 131
Altamura 126
Princeton 120
Nanjing 112
Rome 105
Boardman 100
Lawrence 100
Hefei 95
Milan 92
Dearborn 88
Buffalo 81
San Diego 79
São Paulo 74
Tulsa 59
Helsinki 58
Ludwigshafen am Rhein 57
London 49
Shenyang 49
Orem 48
Chicago 47
Abidjan 45
The Dalles 44
Brussels 38
Izmir 38
Jinan 38
Nanchang 38
Hebei 34
Nuremberg 34
Tianjin 33
Atlanta 32
Changsha 32
Phoenix 29
Naples 27
Rio de Janeiro 27
Ottawa 26
San Paolo di Civitate 26
Chennai 25
Baghdad 24
Guangzhou 23
Belo Horizonte 22
Da Nang 22
Jiaxing 22
Vienna 20
Warsaw 20
Amsterdam 19
Columbus 19
Haiphong 19
Paris 19
Saint Petersburg 19
Seongnam 19
Falls Church 18
Kumar 18
Munich 18
Brasília 17
Denver 17
Johannesburg 17
Shanghai 17
Tashkent 17
Montreal 16
San Francisco 16
Zhengzhou 16
Norwalk 15
Turin 15
Bologna 14
Curitiba 14
Lappeenranta 14
Stockholm 14
Tehran 14
Venice 14
Verona 14
Bari 13
Totale 15.412
Nome #
Double negative (CD19(+)IgG(+)IgD(-)CD27(-)) B lymphocytes: A new insight from telomerase in healthy elderly, in centenarian offspring and in Alzheimer's disease patients. 376
Studio di validazione dell'ACE-R in lingua italiana nella popolazione degli young-old e degli old-old 328
A systematic review of neuropsychiatric symptoms in mild cognitive impairment 310
Movements execution in amnestic mild cognitive impairment and Alzheimer's disease. 301
Ageing: From inflammation to cancer 299
The instruments used by the Italian centres for cognitive disorders and dementia to diagnose mild cognitive impairment (MCI) 299
Effects of levodopa oral bolus on the kinematics of the pointing movements in Parkinson's disease patients. 289
Cognitive impairment in Behcet’s disease patients without overt neurological involvement 286
Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment 274
Blood group does not appear to affect longevity a pilot study in centenarians from Western Sicily 267
Interictal executive dysfunction in migraineurs without aura: relationship with duration and intensity of attacks. 260
Influence of comorbidity and cognitive status on instrumental activities of daily living in amnestic mild cognitive impairment: results from the ReGAl project 260
Genetic epidemiology of autosomal recessive hypercholesterolemia in Sicily: Identification by next-generation sequencing of a new kindred 256
FragClust and TestClust, two informatics tools for chemical structure hierarchical clustering analysis applied to lipidomics. The example of Alzheimer's disease 254
Chronic paroxysmal hemicrania and hemicrania continua responding to topiramate: Two case reports 251
[3H]-DA release evoked by low pH medium and internal H+ accumulation in rat hypothalamic synaptosomes: involvement of calcium ions 251
Circulating Molecular Chaperones in Subjects with Amnestic Mild Cognitive Impairment and Alzheimer's Disease: Data from the Zabùt Aging Project 249
Prognosis of migraine headaches in adolescents: a 10-year follow-up study. 243
Association of estrogen receptor alpha gene with Alzheimer's disease: a case-control study 241
Double Negative (IgG+IgD-CD27-) B Cells are Increased in a Cohort of Moderate-Severe Alzheimer’s Disease Patients and Show a Pro-Inflammatory Trafficking Receptor Phenotype 241
Association between apolipoprotein E epsilon4 allele and apathy in probable Alzheimer's disease. 240
Mild cognitive impairment: a systematic review 234
Frequency and correlates of Subjective Memory Complaints in Parkinson’s disease with and without Mild Cognitive Impairment : data from the Parkinson’s disease cognitive impairment study 232
Comorbidity between depressive symptoms and migraine: preliminary data from the Zabút Aging Project 231
Association between plasma lipid levels and migraine in subjects aged > or =50 years: preliminary data from the Zabùt Aging Project 231
Isolated, subtle, neurological abnormalities in neurologically and cognitively healthy aging subjects 229
Alzheimer’s disease and infections, where we stand and where we go 227
Can Alzheimer disease be a form of type 3 diabetes? 226
Mild cognitive impairment in Parkinson's disease: the Parkinson's disease cognitive study (PACOS) 225
Visuospatial learning is fostered in migraine: evidence by a neuropsychological study 224
Prevalence and profile of mild cognitive impairment in Parkinson's disease 221
Dietary Supplements as Surrogate of Mediterranean Diet in Healthy Smoking Subjects 218
I disturbi comportamentali “clinicamente rilevanti” nella demenza vascolare, nella demenza a corpi di Lewy e nella demenza di Alzheimer: studio su 921 pazienti anziani 215
β-glucans: Ex vivo inflammatory and oxidative stress results after pasta intake 214
Mild behavioral impairment in Parkinson's disease: Data from the Parkinson's disease cognitive impairment study (PACOS) 213
Visual hallucinations and agitation in Alzheimer's Disease due to memantine: report of three cases 212
Metabolomic analysis of plasma from Alzheimer disease patients 212
Neuropsychiatric symptoms in 921 elderly subjects with dementia: a comparison between vascular and neurodegenerative types. 210
Double Negative (CD19+IgG+IgD-CD27-) B Lymphocytes: A New Insight from Telomerase in Healthy Elderly, in Centenarian Offspring, and in Alzheimer’s Disease Patients 210
No association between the cystatin C gene polymorphism and Alzheimer's disease: a case-control study in an Italian population. 208
Potential drug-drug interaction between duloxetine and acenocoumarol in a patient with Alzheimer's disease 203
The symptom of low mood in the prodromal stage of mild cognitive impairment and dementia: a cohort study of a community dwelling elderly population 201
Effects of 8-OH-DPAT on open field performance of young and aged rats prenatally exposed to diazepam: a tool to rveal 5-HT1a receptor function 201
SHIP2: A ‘‘NEW’’ Insulin Pathway Target for Aging Research 195
The C(-260)>T gene polymorphism in the promoter of the CD14 monocyte receptor gene is not associated with acute myocardial infarction 194
Incidence of mild cognitive impairment and dementia in Parkinson's disease: The Parkinson's disease cognitive impairment study 193
A new intraoral device to home assist Parkinson’s disease patients by distant control 191
Mediterranean diet and longevity in Sicily: survey in a Sicani Mountains population 191
Anxiety disorder, depression and chronic daily headache: a case-control study. 190
Chronic headache and body mass index: a case-control study. 190
Predictors of progression from mild cognitive impairment to Alzheimer disease 187
The neuropsychiatric profile of Parkinson's disease subjects with and without mild cognitive impairment 186
Amyloid precursor protein in platelets: a peripheral marker for the diagnosis of sporadic AD. 186
Lymphocytic mitochondrial aconitase activity is reduced in Alzheimer's disease and mild cognitive impairment 185
Cognitive performance in elderly patients undergoing carotid endarterectomy or carotid artery stenting: A twelve-month follow-up study 184
Migraine headaches in adolescents: a five-year follow-up study 181
Comment on "Sleep disturbances and later cognitive status: a multi-centre study" 179
Electrocortical networks in Parkinson's disease patients with Mild Cognitive Impairment. The PaCoS study 178
Occurrence of cognitive impairment and dementia in the community: a 9-year-long prospective study 176
Migraine mediates the influence of C677T MTHFR genotypes on ischemic stroke risk with a stroke-subtype effect. 175
Validation study of the Italian Addenbrooke's Cognitive Examination Revised in a young-old and old-old population 174
Five-year longitudinal study of juvenile migraine headaches 174
HETEROGENEITY IN RISK FACTORS FOR COGNITIVE IMPAIRMENT, NO DEMENTIA: Population-Based Longitudinal Study From the Kungsholmen Project. 172
Behavioral and psychological effects of coronavirus disease-19 quarantine in patients with dementia 170
TRANS-CRANIAL MRI-GUIDED FOCUSED ULTRASOUND SURGERY (TCMRGFUS): PRELIMINARY ITALIAN (AND WORLD-FIRST) EXPERIENCE AT 1,5 TESLA (first 3 cases treated) 170
Lack of association between angiotensin converting enzyme polymorphism and sporadic Alzheimer's disease 168
Being the Family Caregiver of a Patient With Dementia During the Coronavirus Disease 2019 Lockdown 167
Vascular risk factors in mild cognitive impairment subtypes. Findings from the ReGAl project 166
Cardiovascular autonomic function and MCI in Parkinson's disease 165
ORAL HEALTH STATUS AND PERIODONTITIS IN ALZHEIMER'S DISEASE:A POPULATION-BASED, CASE-CONTROL STUDY FROM THE ZABUT AGING PROJECT 163
Migraine without aura as a possible sign of covert neurological involvement in Behcet's disease: a case-control study 163
POST-THALAMOTOMY NEUROFUNCTIONAL FINDINGS ON PATIENTS TREATED WITH TRANS-CRANIAL MAGNETIC RESONANCE GUIDED FOCUSED ULTRASOUND SURGERY (TCMRGFUS): PRELIMINARY RESULTS 158
Erratum: FragClust and TestClust, two informatics tools for chemical structure hierarchical clustering analysis applied to lipidomics. The example of Alzheimer's disease (Analytical and Bioanalytical Chemistry DOI: 10.1007/s00216-015-9229-6) 158
Prevalence of headache in patients with Behçet's disease without overt neurological involvement 157
Tower of London test: a comparison between conventional statistic approach and modelling based on artificial neural network in differentiating fronto-temporal dementia from Alzheimer's disease 156
Oral health status and periodontitis in Alzheimer's disease patients: A case control Study in a Sicilian rural community 156
The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design 156
Malattie delle meningi e neurolue 153
No association between Glu298Asp endothelial nitric oxide synthase polymorphism and Italian sporadic Alzheimer's disease 152
Mild cognitive impairment predicts the onset of Sarcopenia: a longitudinal analysis from the English Longitudinal Study on Ageing 151
Oral Health Status in Subjects with Amnestic Mild Cognitive Impairment and Alzheimer's Disease: Data from the Zabút Aging Project 151
Apoe genotype influences the biological effects of AChe inhibitors on platelet APP metabolism 150
TREM 2 in Parkinson’s Disease: A Promising Candidate Gene for Disease Susceptibility and Progression 149
Risk factors for cognitive impairment in subjecys with Behcet's disease 148
Prevalence and pattern of cognitive impairment in systemic lupus erythematosus patients with and without overt neuropsychiatric manifestations 148
A promising therapeutic peptide and preventive/diagnostic biomarker for age-related diseases: The Elabela/Apela/Toddler peptide 148
Focus of endothelial glycocalyx dysfunction in ischemic stroke and Alzheimer’s disease: possible intervention strategies 146
Red ear syndrome and migraine: report of eight cases. 143
Voxel-Based Morphomerty study in patients with amnestic Mild Cognitive Impairment and Alzheimer's Disease: population-based data from the Zabùt Aging Project 142
Metabolic syndrome, mild cognitive impairment and dementia: data from the cognitive impairment through aging 141
Preclinical Dementia: An Italian Multicentre Study on Amnestic Mild Cognitive Impairment 141
Encefaliti 137
Intracerebral haemorrhage associated with sildenafil citrate 137
Amyloid precursor protein in platelets of patients with Alzheimer disease: Effect of acetylcholinesterase inhibitor treatment 136
Diagnosis and therapeutic management of primary headache in an emergency setting 134
Accuracy of the clinical diagnosis of dementia with Lewy bodies (DLB) among the Italian Dementia Centers: a study by the Italian DLB study group (DLB-SINdem) 134
Clinical Evaluation of a Telemedically Linked Intraoral Drug Delivery System 133
Cognitive deficits in beta-thalassemia major 132
Azathioprine and mycophenolate mofetil in myasthenia gravis 131
Imaging of substantia nigra in parkinson’s disease: A narrative review 131
Totale 19.794
Categoria #
all - tutte 87.897
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87.897


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.426 83 286 47 66 52 53 62 79 166 175 81 276
2022/20231.971 185 398 47 192 158 311 137 136 176 82 105 44
2023/20241.007 61 108 43 73 77 187 103 71 18 42 42 182
2024/20252.925 85 203 178 259 119 108 232 202 276 325 339 599
2025/20269.803 710 237 802 753 887 1.341 1.328 950 762 1.013 504 516
2026/2027280 280 0 0 0 0 0 0 0 0 0 0 0
Totale 25.029